Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098744 · ClinicalTrials.gov registry record · Phase 2
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
A Phase 2 study of HPV Infection and Cervical Dysplasia, sponsored by Frantz Viral Therapeutics.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
- 7
- Study locations
NCT04098744 is a Phase 2 study of HPV Infection and Cervical Dysplasia that is actively recruiting participants, run by Frantz Viral Therapeutics. The registered enrollment target is 78 participants, below the 230-participant average among 13 other HPV Infection trials with a reported enrollment target (66% lower). The trial reports 7 study locations across 4 states.
The verdict
NCT04098744, a Phase 2 study of HPV Infection and Cervical Dysplasia, is actively recruiting participants, sponsored by Frantz Viral Therapeutics.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).
Conditions Studied
Interventions
- DRUG Artesunate vaginal insert
- DRUG Placebo vaginal insert
Study Locations (7)
Ohio
- Cleveland Clinic Fairview Hospital - Cleveland
- Cleveland Clinic Foundation - Cleveland
- Hillcrest Hospital - Mayfield Heights
Texas
- The Harris Health System (L.B.J Hospital) - Houston
- University of Texas, M.D. Anderson - Houston
Florida
- Florida Gynecologic Oncology - Fort Myers
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04098744
The ClinicalTrials.gov registry entry for NCT04098744 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 13 other HPV Infection trials with a reported enrollment target (66% lower). The listed sponsor is Frantz Viral Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with HPV Infection appearing as the primary indexed condition, and to 2 interventions - of which Artesunate vaginal insert is the first listed.
NCT04098744 reports 7 study locations spanning 4 distinct geographic areas - top geographies include Ohio, Texas, Florida.
Frequently Asked Questions
What is clinical trial NCT04098744 about?
NCT04098744 is a clinical study titled "Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)". This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).
What is the current status of trial NCT04098744?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2020-09-09. Estimated completion is 2026-12-31.
What conditions does trial NCT04098744 study?
This clinical trial studies the following conditions: HPV Infection, Cervical Dysplasia, Pre-Cancerous Dysplasia, CIN 2/3, HPV Related Disease.
What interventions are being tested in trial NCT04098744?
The interventions under investigation include: Artesunate vaginal insert (DRUG), Placebo vaginal insert (DRUG).
Who is sponsoring clinical trial NCT04098744?
This trial is sponsored by Frantz Viral Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04098744 being conducted?
This trial has 7 study locations across Florida, Michigan, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
RECRUITING · Phase 2
-
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
ACTIVE NOT RECRUITING · Phase 2
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
PCOM2 - The Physician Communication Intervention, Version 2.0
RECRUITING · NA
-
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
RECRUITING · Phase 4
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.